Institutional Investor Sentiment About Accuray Inc (NASDAQ:ARAY) Improved

Accuray Incorporated (NASDAQ:ARAY) Logo

Sentiment for Accuray Inc (NASDAQ:ARAY)

Accuray Inc (NASDAQ:ARAY) institutional sentiment decreased to 1.39 in 2019 Q1. Its down -0.53, from 1.92 in 2018Q4. The ratio is negative, as 68 investment professionals opened new or increased holdings, while 49 sold and trimmed stakes in Accuray Inc. The investment professionals in our partner’s database now have: 67.32 million shares, up from 66.74 million shares in 2018Q4. Also, the number of investment professionals holding Accuray Inc in their top 10 holdings increased from 0 to 2 for an increase of 2. Sold All: 19 Reduced: 30 Increased: 43 New Position: 25.

Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body. The company has market cap of $269.35 million. The firm offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. It currently has negative earnings. The CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, as well as enables the delivery of precise, high dose radiation while patients breathe normally.

The stock decreased 8.66% or $0.29 during the last trading session, reaching $3.06. About 2.23 million shares traded or 282.84% up from the average. Accuray Incorporated (NASDAQ:ARAY) has risen 10.40% since August 15, 2018 and is uptrending. It has outperformed by 10.40% the S&P500.

Archon Capital Management Llc holds 4.16% of its portfolio in Accuray Incorporated for 3.20 million shares. Lapides Asset Management Llc owns 1.07 million shares or 1.93% of their US portfolio. Moreover, Adirondack Research & Management Inc. has 1.58% invested in the company for 532,262 shares. The Wisconsin-based Heartland Advisors Inc has invested 1.21% in the stock. Eam Investors Llc, a California-based fund reported 199,266 shares.

More notable recent Accuray Incorporated (NASDAQ:ARAY) news were published by: Seekingalpha.com which released: “Week In Review: Wild Trading On Opening Day At Shanghai STAR Exchange; Shenzhen Chipscreen To IPO On STAR Next Week – Seeking Alpha” on July 28, 2019, also Seekingalpha.com with their article: “ViewRay: Failed Product Launch Raises Solvency Questions – Seeking Alpha” published on August 13, 2019, Benzinga.com published: “Earnings Scheduled For August 15, 2019 – Benzinga” on August 15, 2019. More interesting news about Accuray Incorporated (NASDAQ:ARAY) were released by: Seekingalpha.com and their article: “Accuray launches new image guidance system – Seeking Alpha” published on April 24, 2019 as well as Nasdaq.com‘s news article titled: “Better Buy: Intuitive Surgical vs. Accuray – Nasdaq” with publication date: January 18, 2019.

Accuray Incorporated (NASDAQ:ARAY) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.